BCWorldPharm Co Ltd banner
B

BCWorldPharm Co Ltd
KOSDAQ:200780

Watchlist Manager
BCWorldPharm Co Ltd
KOSDAQ:200780
Watchlist
Price: 4 435 KRW 2.9%
Market Cap: ₩47.3B

BCWorldPharm Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BCWorldPharm Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
B
BCWorldPharm Co Ltd
KOSDAQ:200780
EPS (Diluted)
-₩527
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
EPS (Diluted)
₩2.6k
CAGR 3-Years
27%
CAGR 5-Years
-3%
CAGR 10-Years
3%
SK Biopharmaceuticals Co Ltd
KRX:326030
EPS (Diluted)
₩3.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
EPS (Diluted)
₩13.4k
CAGR 3-Years
27%
CAGR 5-Years
68%
CAGR 10-Years
0%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
EPS (Diluted)
-₩490
CAGR 3-Years
-292%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
EPS (Diluted)
₩582
CAGR 3-Years
-39%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
No Stocks Found

BCWorldPharm Co Ltd
Glance View

Market Cap
47.3B KRW
Industry
Pharmaceuticals

BCWORLD PHARM.Co., Ltd. engages in the manufacture and development of pharmaceutical products. The company is headquartered in Yeoju, Gyeonggi-Do. The company went IPO on 2014-12-15. The firm's products include anesthetic pain medication such as cancer pain treatment, muscle relaxants, anesthesia and pain relief drugs; circulation contracts such as hypertension and hyperlipidemia; antibiotics such as tuberculosis treatment; other prescription drugs such as peptic ulcer and osteoporosis. In addition, the Company develops improved drugs and new products.

Intrinsic Value
5 422.46 KRW
Undervaluation 18%
Intrinsic Value
Price ₩4 435
B

See Also

What is BCWorldPharm Co Ltd's EPS (Diluted)?
EPS (Diluted)
-527 KRW

Based on the financial report for Dec 31, 2025, BCWorldPharm Co Ltd's EPS (Diluted) amounts to -527 KRW.

What is BCWorldPharm Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
-21%

Over the last year, the EPS (Diluted) growth was -21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett